PharmaMedic announces 2nd Virtual Breakfast Briefing for Consultants on 22nd April 2021
Following the success of our first virtual breakfast briefing in February 2021, PharmaMedic invites consultants and those thinking of becoming [...]
3 ways medical affairs consultants added value during the COVID-19 Crisis
We've championed the benefits of outsourced medical affairs solutions for over a decade. During the last 12 months, the [...]
Key takeaways from our first breakfast briefing, February 2021
We enjoyed welcoming delegates to our first virtual breakfast briefing earlier this month discussing the trends shaping medical and regulatory [...]
The role of regulatory affairs in enabling innovation
As 2021 gets underway, in the context of continued pandemic response and post-Brexit environment, the role of regulatory affairs in [...]
London Bioscience Innovation Centre (LBIC) five years on
We marked our 5-year anniversary as a client of the London Bioscience Innovation Centre (LBIC) recently and featured in its [...]
Year-end Round-Up – Your favourite PharmaMedic articles of 2020
2020 was certainly one of the most unusual years we can recall. Thank you to our clients, consultants [...]
PharmaMedic announces Virtual Breakfast Briefing on 10th February 2021
PharmaMedic is delighted to announce the launch of a new series of virtual events starting with a breakfast briefing on [...]
Congratulations to Takeda UK and Makara Health on their recognition at the PMEA Awards
PharmaMedic was delighted to support and sponsor the Excellence in Rare Diseases and Orphan Drugs category at the recent PMEA [...]
Client Q&A: Dr Kathrine Scott, Gedeon Richter
In our latest article, we explore how PMC supports Dr Kathrine Scott of Gedeon Richter with new product launches and [...]
Building a brighter future for rare disease patients
The number of clinical trials for orphan conditions has grown significantly in the past decade. New advances in genomics [...]
PMC® Announces Sponsorship of PMLiVE Pharmaceutical Market Excellence Awards
PharmaMedic Consultancy is delighted to announce its sponsorship of the ‘Excellence in Rare Diseases and Orphan Drugs" category at the [...]
Download our Capabilities Brochure
To learn more about our flexible solutions and how we support customers from start-up to post-approval, download our capabilities brochure.
An independent future for the MHRA
From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be making independent regulatory decisions. Guidelines are [...]
Client Q&A: Olivia Marsh, Glenmark Pharmaceuticals
In our latest article, we explore how PharmaMedic Consultancy (PMC®) supports Glenmark Pharmaceuticals with their day to day promotional activities. [...]
To succeed with a Marketing Authorisation extension or Variation, it is essential that Regulatory and Medical Affairs Teams work hand in hand
Collaboration is essential to drive innovation in pharma and bring new medicines to patients. In this article, we discuss [...]